Viited
-
- Atherton DJ, Proksch E, Schauber J, Stalder JF. Irritant diaper dermatitis: best practice management. SelfCare. 2015; 6(S1): 1–11.
- EEbner F, Heller A. at al. Topical use of dexpanthenol in skin disorders. American journal of clinical dermatology 2002;3(6): 427–433.
- Heise R, Skazik C, Marquardt Y, et al. Dexpanthenol modulates gene expression in skin wound healing in vivo. Skin Pharmacology and Physiology. 2012; 25: 241–248.
- Lacroix B, Didier E, Grenier JF. Effects of pantothenic acid on fibroblastic cell cultures. Research in Experimental Medicine. 1988; 188: 391–396.
- Porksch E, de Bony R, Trapp S, Boudon S. Topical use of dexpanthenol: a 70th anniversary article. The Journal of dermatological treatment. 2017 Dec;28(8):766–773
- Proksch E, Nissen HP.
- Dexpanthenol enhances skin barrier repair and reduces inflammation after sodium lauryl sulphate-induced irritation. The Journal of dermatological treatment. 2002; 13: 173–178.
- Wiederholt T, Heise R, Skazik C, et al. Calcium pantothenate modulates gene expression in proliferating human dermal fibroblasts. Experimental Dermatology. 2009; 18: 969–978.
- Salv RECREOL® (Dexpanthenolum 50 mg/g), ravimikirjeldus.
- Kreem RECREOL® (Dexpanthenolum 50 mg/g), ravimikirjeldus.
